Ashish Khanna, MD, on the PRODIGY Trial and Risk Score

Dr Ashish Khanna, from Wake Forest School of Medicine, discusses his research on a novel opioid-induced respiratory depression risk score, its benefits for practice, and more.

Ashish Khanna MD, is an associate professor in the Department of Anesthesiology, Section on Critical Care Medicine, at the Wake Forest School of Medicine in Winston-Salem, North Carolina.

Additional Reading:
Khanna A, Buhre W, Saager L, et al. Derivation and validation of a novel opioid-induced respiratory depression risk prediction tool. Crit Care Med. 2019;47(1):18. doi:10.1097/01.ccm.0000550828.76036.ba.
PRediction of Opioid-induced Respiratory Depression In Patients Monitored by capnoGraphY (PRODIGY) Trial